LEO PHARMA A/S: Financial statements 2013
CVR: 56759514
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 5,782,000,000 and a net result of DKK 1,175,000,000. The profit margin was 20.3%. Equity in the 2013 report amounted to DKK 23,136,000,000. The solvency ratio was 70.1%. The company had 4,733 employees in the financial year.
- Revenue
- DKK 5,782,000,000
- Profit/Loss
- DKK 1,175,000,000
- Equity
- DKK 23,136,000,000
- Total Assets
- DKK 33,004,000,000
- Employees
- 4,733
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
LEO PHARMA A/S has published its annual report for 2012.
About LEO PHARMA A/S
LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Christophe Dominique Luc Charles Bourdon and Philip Harald Eickhoff. The board consists of Jesper Brandgaard (chair), Paul Olivier Marie Navarre, Peter Helt Jacobsen Haahr and Aino Anna Liisa Hurme. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 1,047 employees (2026). In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity in the 2025 report amounted to DKK 5,262,000,000.